Plain-English translation of NCT07585994 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes Mellitus research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a probiotic supplement called Desulfovibrio piger can help people with long-standing type 1 diabetes. Researchers believe this bacteria may help reduce inflammation in the gut and improve how the immune system works, which could preserve the body's remaining ability to make insulin. Half of the participants will receive the medication daily for 4 weeks, and half will receive a placebo (a harmless dummy treatment).
Type 1 diabetes happens when the immune system attacks the cells that make insulin. Even after many years, some people still have a few of these cells left, and researchers want to know if this medication might help protect and preserve them by calming down the immune response.
You likely qualify if…
You likely don't qualify if…
You would take a daily dose of either the probiotic supplement or a placebo for 4 weeks. During this time, you'll have blood tests, provide stool samples, wear a continuous glucose monitor to track your blood sugar, and answer questions about how you're feeling. The study lasts 6 weeks total—4 weeks of treatment plus a 2-week period where you stop taking the supplement so researchers can see if any effects last.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Netherlands